Metraipolis › archive › dc_a1944e7972bd
Utility of inhaled β2-agonists in reducing serum potassium levels in adult patients with hyperkalemia: A scoping review — Europe PMC PMID:41632760
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41632760
- DOI
- 10.1371/journal.pone.0342309
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T04:01:19.857Z
- SHA-256 of the archived text
1d31263ff4ab1b849ab6ca9723ee4a077c8765b1a34486983a89ae559b22d268- Stable URL of this page
https://metraipolis.com/documento/dc_a1944e7972bd
How to cite
Utility of inhaled β2-agonists in reducing serum potassium levels in adult patients with hyperkalemia: A scoping review — Europe PMC PMID:41632760 — Europe PMC (en), https://europepmc.org/article/MED/41632760 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a1944e7972bd (Metraipolis archive dc_a1944e7972bd, sha256 1d31263ff4ab1b849ab6ca9723ee4a077c8765b1a34486983a89ae559b22d268)
BibTeX
@misc{dca1944e7972bd,
title = {Utility of inhaled β2-agonists in reducing serum potassium levels in adult patients with hyperkalemia: A scoping review — Europe PMC PMID:41632760},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41632760},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a1944e7972bd; sha256 1d31263ff4ab1b849ab6ca9723ee4a077c8765b1a34486983a89ae559b22d268},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41632760. Agents can read the archived copy with the MCP tool read_document.